Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
Åç¼ÕÁ¤ - »õâ
|
¸ÞµðÄ«ÄÚ¸®¾Æ |
A10050391 | Tolperisone HCl | Àü¹®ÀǾàǰ | ºñ±Þ¿© |
|
ÅçÆä¼ÕÁ¤150mg - »õâ
|
À§´õ½º¸ÞµðÆÊ |
A03750411 | Tolperisone HCl | Àü¹®ÀǾàǰ | ºñ±Þ¿© |
|
Æä¸®¼ÕÁ¤150mg - »õâ
|
½ÅdzÁ¦¾à |
A00305061 | Tolperisone HCl | Àü¹®ÀǾàǰ | ºñ±Þ¿© |
|
¾Ë¸®ÄÚ¿°»êÅçÆä¸®¼ÕÁÖ - »õâ
|
Çѱ¹¾Ë¸®ÄÚÆÊ |
A06651881 | Tolperisone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¾ËÆÄ¿°»êÅçÆä¸®¼ÕÁÖ»ç - »õâ
|
¾ËÆÄÁ¦¾à |
A23551771 | Tolperisone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µðÆ®·ç½ÃÅçSRݼ¿4mg - »õâ
|
ÆÄ¸¶½Ã¾ÆÄÚ¸®¾Æ |
E00130421 | Tolterodine l-tartrate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
ÅçÆäÁ¤150mg - »õâ
|
¿µÇ³Á¦¾à |
A25055311 | Tolperisone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
ÅçÆä·ÐÁ¤150mg - »õâ
|
¹Ì·¡Á¦¾à |
A20652591 | Tolperisone HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µðÆ®·ç½ÃÅçSRݼ¿2mg - »õâ
|
ÆÄ¸¶½Ã¾ÆÄÚ¸®¾Æ |
E00130471 | Tolterodine l-tartrate | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µðÆ®·ç½ÃÅçÁ¤1mg - »õâ
|
Çѱ¹ÈÀÌÀÚ |
E01890431 | Tolterodine l-tartrate | Àü¹®ÀǾàǰ | ±Þ¿© |
| tolerance |
Decreased sensitivity to the effects of a substance such as a medication.
Ãâó: professionals.epilepsy.com/page/glossary.html
|
|---|---|
| toluene |
Used sa solvent in cosmetics, especially nail polish, and also dyes. It is used in pharmaceuticals and gasoline as a blending agent. It is toxic and narcotic in high concentrations.
Ãâó: beautyskin.tripod.com/MALL.HTM
|
| tolerance |
The ability to experience exposure to potentially harmful amounts of a substance without showing an adverse effect. (IPCS) In immunology, the ability of a host to recognise its own proteins without developing an immune response.
Ãâó: www.bseinquiry.gov.uk/report/volume16/gloss5.htm
|
| tolerance |
Condition in which a person must keep increasing the dosage of a drug to maintain the same effect. Tolerance develops with the barbiturates, amphetamines and related compounds, and opiates.
Ãâó: www.addiction-rehabilitation.com/glossary.html
|
| tolcapone |
A drug in the COMT inhibitor class that is sometimes prescribed in tandem with levodopa. The drug has been known to cause serious liver problems and has been withdrawn from the Canadian and European markets.
Ãâó: www.michaeljfox.org/parkinsons/glossary.php
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|